Combination of Vaccine-Strain Measles and Mumps Viruses Enhances Oncolytic Activity against Human Solid Malignancies

Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing

(2016) Darren Qiancheng Tan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Safety and Immunogenicity of M-M-RII (Combination Measles–Mumps–Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009

(2016) Barbara J. Kuter et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells

(2016) Yosuke Amagai et al.   Scientific Reports

Development of new therapy for canine mammary cancer with recombinant measles virus

(2016) Koichiro Shoji et al.   Molecular Therapy-Oncolytics

Recombinant mumps virus as a cancer therapeutic agent

(2016) Arun Ammayappan et al.   Molecular Therapy-Oncolytics

A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells

(2015) Tomoko Fujiyuki et al.   Oncotarget

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency

(2015) Olga V Matveeva et al.   Molecular Therapy-Oncolytics

Oncolysis by paramyxoviruses: preclinical and clinical studies

(2015) Olga V Matveeva et al.   Molecular Therapy-Oncolytics

Molecular imaging of oncolytic viral therapy

(2015) Dana Haddad et al.   Molecular Therapy-Oncolytics

Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia

(2014) Li Feng Zhang et al.   CANCER LETTERS

Many faces of DAMPs in cancer therapy

(2013) O Krysko et al.   Cell Death & Disease

Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

(2012) E. M. Karapanagiotou et al.   CLINICAL CANCER RESEARCH

Attenuated, Oncolytic, but Not Wild-Type Measles Virus Infection Has Pleiotropic Effects on Human Neutrophil Function

(2011) Y. Zhang et al.   JOURNAL OF IMMUNOLOGY

Use of attenuated paramyxoviruses for cancer therapy

(2010) Patrycja J Lech et al.   Expert Review of Vaccines

Intelligent Design: Combination Therapy With Oncolytic Viruses

(2009) Kathryn Ottolino-Perry et al.   MOLECULAR THERAPY

Heat shock protein inhibitors increase the efficacy of measles virotherapy

(2008) C Liu et al.   GENE THERAPY

STAT2 Is a Primary Target for Measles Virus V Protein-Mediated Alpha/Beta Interferon Signaling Inhibition

(2008) A. Ramachandran et al.   JOURNAL OF VIROLOGY